HIV 1 News and Research

RSS

Research shows new Zika virus vaccine that offers 100% protection in mice

Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice.

5 Jun 2017

CDC warning on Salmonella infections in humans from backyard poultry

CDC and other U.S health services are investigating eight multistate outbreaks of human Salmonella infections linked to contact with poultry living in the backyards.

5 Jun 2017

TSRI study reveals first-ever structure of Lassa virus protein

Before Ebola virus ever struck West Africa, locals were already on the lookout for a deadly pathogen: Lassa virus. With thousands dying from Lassa every year-;and the potential for the virus to cause even larger outbreaks- researchers are committed to designing a vaccine to stop it.

1 Jun 2017

Tobacco use more common among HIV positive individuals, York study shows

Researchers at the University of York have shown that tobacco use is more common among HIV positive individuals than HIV negative individuals.

1 Jun 2017

Supportive housing linked to improvements in health of formerly homeless people with HIV/AIDS

Ask Elizabeth Bowen about the intersection of homelessness and HIV/AIDS in the United States and she'll respond without hesitation, "Housing equals health."

1 Jun 2017

HPV infection more likely to develop into cervical pre-cancer in women with HIV

A study of Senegalese women showed that human papillomavirus (HPV) infection was more likely to develop into cervical pre-cancer in women living with human immunodeficiency virus.

1 Jun 2017

Scientists could be one step closer to developing vaccines against viruses

Scientists could be one step closer to developing vaccines against viruses such as Zika, West Nile or HIV, according to Penn State College of Medicine researchers.

31 May 2017

Majority of adolescent girls in conflict settings are victimized by violence, study reveals

A majority of displaced adolescent girls are victimized by violence, according to a new study in the Democratic Republic of Congo and Ethiopia by researchers at Columbia University's Mailman School of Public Health.

30 May 2017

Scientists create a faster, less labor-intensive test to detect “hidden” HIV

The search to develop a HIV cure has long been overwhelmed by a seemingly simple question: How do physicians find out if somebody is cured? The virus has an ability to lie dormant in immune cells at levels that could not be detected to all, however, the most expensive and time-consuming tests can find the hidden virus.

30 May 2017

Scripps scientists make important advance in HIV vaccine design

Scientists at The Scripps Research Institute (TSRI) have made another important advance in HIV vaccine design. The development was possible thanks to previous studies at TSRI showing the structures of a protein on HIV’s surface, called the envelope glycoprotein. The scientists used these structures to design a mimic of the viral protein from a different HIV subtype, subtype C, which is responsible for the majority of infections worldwide.

29 May 2017

Dual therapy effective as second-line treatment for patients infected by HIV with multiple mutations

ANRS 12286 MOBIDIP, a clinical trial running in parallel in three countries in sub-Saharan Africa (Cameroon, Burkina Faso, and Senegal), shows that dual therapy with lamivudine and a boosted protease inhibitor is effective as second-line treatment in patients infected by HIV with multiple mutations.

29 May 2017

Grifols provides Procleix Zika Virus Assay to screen blood donations in countries that accept products with CE marking

Grifols, one of the world’s leading producers of plasma-derived medicines, now provides European countries accepting products with the CE marking with a test to detect the presence of the Zika virus in donated blood. CE marking means a product conforms to relevant legislation for sale in the European economic area.

29 May 2017

New study finds clear trend of HIV patients persisting with treatment longer than usual

With antiretroviral drugs, HIV has become a manageable chronic condition, but only so long as patients continue to take the medication.

26 May 2017

WHO announces new flagship programs for African region over next two years

The World Health Organization’s Regional Director for Africa announced today four new flagship programs for the region over the next two years, including a major push on adolescent health and the creation of regional emergency hubs.

26 May 2017

Researchers develop new method for rapidly sorting HIV viruses

Researchers at EMBL, ESPCI Paris, and the International AIDS Vaccine Initiative have developed a new technique for rapidly sorting HIV viruses, which could lead to more rapid development of a vaccine for HIV, as they report in Cell Chemical Biology.

25 May 2017

U-M research reveals important clues about invasion of polyomaviruses

Every cell in our body runs like a tiny factory that makes specialized products, using the carefully guarded instructions kept in the CEO's office.

24 May 2017

Study: Spouses of Nepali migrant workers at higher risk of HIV

Traveling abroad to work or study has become a national trend in Nepal, especially in the young male population. Over three million Nepali migrant workers are in the Middle East, Malaysia and India.

23 May 2017

New navigation program improves outcomes, longevity of care for HIV-infected adolescents and youth

Enrolling adolescents and young adults living with HIV in a program to help navigate care significantly increases the number of youths who remained in care compared with national estimates, according to study published in the Journal of the American Medical Association Pediatrics.

23 May 2017

New study finds inequalities in healthcare access, quality between best and worst-performing countries

Despite global improvements in healthcare quality and access over 25 years, inequalities between the best and worst-performing countries have grown.

22 May 2017

Directly observed therapy linked to decrease in mortality among MDR TB patients

Directly observed therapy (DOT) for multidrug-resistant tuberculosis (MDR TB) was associated with a 77 percent decrease in mortality in the United States, compared to self-administered therapy from 1993 to 2013, according to new research presented at the ATS 2017 International Conference.

22 May 2017